HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

R peptide

a substrate for one or more forms of CDC2 kinase; amino acid sequence is KSPAKTPVK

Networked: 7 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - R peptide: 7

Experts

1.	Hayashi, Hideki: 1 article (01/2019)
2.	Izumida, Mai: 1 article (01/2019)
3.	Jin, Sae Young: 1 article (01/2019)
4.	Jung, Yong-Tae: 1 article (01/2019)
5.	Kang, Byeng Kwon: 1 article (01/2019)
6.	Kubo, Yoshinao: 1 article (01/2019)
7.	Lee, Eun Sik: 1 article (01/2019)
8.	Togawa, Kei: 1 article (01/2019)
9.	Zhang, Fengmin: 1 article (01/2019)
10.	Abdalla, Mohamed O: 1 article (01/2017)

Related Diseases

1.	Infections 01/01/2007 - "The role of R peptide cleavage in amphotropic, polytropic, and xenotropic MLV infection has not been investigated. " 01/01/2019 - "Consistent with this result, R-peptide-containing Env protein had less efficient inhibition of E-MLV vector infection than R-peptide-truncated Env protein. " 04/29/2005 - "The process of A-MuLV infection requires cleavage of the R peptide from the envelope protein. " 01/15/2005 - "We report the infection of adult BALB/c, C3H/He, 129Sv, and 129Sv IFNAR(-/-) mice with an infectious chimeric HTLV-I provirus bearing the Moloney-murine leukemia virus (Mo-MuLV) envelope glycoprotein truncated for the C-terminal R peptide. "
2.	Thyroid Diseases (Thyroid Disease) 06/01/2013 - "Immunogenic reaction to hTSH-R peptide 37 was partially suppressed by 37 m, and this may contribute to immunotherapy of autoimmune thyroid disease."
3.	Prostatic Neoplasms (Prostate Cancer) 01/01/2017 - "As an alternative therapeutic treatment to reduce or eliminate the current side effects associated with advanced prostate cancer (PCa) chemotherapy, a multifunctional double-receptor-targeting iron oxide nanoparticles (IONPs) (luteinizing hormone-releasing hormone receptor [LHRH-R] peptide- and urokinase-type plasminogen activator receptor [uPAR] peptide-targeted iron oxide nanoparticles, LHRH-AE105-IONPs) drug delivery system was developed. "
4.	Neoplasms (Cancer) 01/01/2019 - "In addition, to lyse tumor cells by syncytium, MoMLV-10A1-R(-)-EGFP was generated by replacing wild-type 10A1 env with the 16-amino acid R peptide-truncated 10A1 env gene. "

Related Drugs and Biologics

1.	Urokinase Plasminogen Activator Receptors
2.	env Gene Products
3.	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)
4.	Proteins (Proteins, Gene)
5.	Peptides (Polypeptides)
6.	Gonadotropin-Releasing Hormone (GnRH)
7.	Glycoproteins (Glycoprotein)
8.	Acids

Related Therapies and Procedures

1.	Immunotherapy
2.	Drug Therapy (Chemotherapy)